Bausch & Lomb Corp | Business Contracts

New Hire Stock Option Grant Agreement (Non-Statutory Stock Option) under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (Brenton L. Saunders) (Filed With SEC on May 3, 2023)

New Hire Restricted Share Unit Grant Agreement under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (Brenton L. Saunders) (Filed With SEC on May 3, 2023)

New Hire Share Unit Grant Agreement (Performance Restricted Share Units) under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (Brenton L. Saunders) (Filed With SEC on May 3, 2023)

Form of Stock Option Grant Agreement (Non-Qualified Stock Option) under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (Filed With SEC on May 3, 2023)

Form of Share Unit Award Agreement (Restricted Share Units) under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (Filed With SEC on May 3, 2023)

Form of Share Unit Award Agreement (Performance Restricted Share Units Relative TSR) under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (Filed With SEC on May 3, 2023)

Form of Share Unit Award Agreement (Performance Restricted Share Units Organic Revenue Growth) under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (Filed With SEC on May 3, 2023)

Bausch + Lomb Corporation 2022 Omnibus Incentive Plan, as amended and restated effective as of April 24, 2023 (Filed With SEC on May 3, 2023)

Employment Agreement dated as of August 1, 2022 by and between Bausch + Lomb Corporation and Yehia Hashad (Filed With SEC on May 3, 2023)

Employment Agreement dated as of February 14, 2023 by and between Bausch + Lomb Corporation and Brenton L. Saunders (Filed With SEC on February 22, 2023)

Amended and Restated Separation Agreement dated December 22, 2022 between Bausch + Lomb Corporation and Joseph C. Papa (Filed With SEC on February 22, 2023)

Form of Matching Share Grant Agreement under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (Filed With SEC on February 22, 2023)

Form of Restricted Share Unit Award Agreement pursuant to the 2022 Omnibus Incentive Plan (Filed With SEC on November 2, 2022)

Form of Executive Committee Retention Program Letter Agreement (Filed With SEC on November 2, 2022)

Separation Agreement dated July 19, 2022 between Bausch + Lomb Corporation and Joseph C. Papa (Filed With SEC on November 2, 2022)

Amended and Restated Director Appointment and Nomination Agreement between Bausch + Lomb Corporation and the Icahn Group dated as of June 21, 2022 (Filed With SEC on June 23, 2022)

Amendment to Master Separation Agreement by and between Bausch Health Companies Inc. and Bausch + Lomb Corporation, dated as of April 28, 2022 (Filed With SEC on April 28, 2022)

Director Appointment and Nomination Agreement between Bausch + Lomb Corporation and the Icahn Group dated as of April 28, 2022 (Filed With SEC on April 28, 2022)

Letter Agreement among Bausch + Lomb Corporation, Bausch Health Companies Inc. and Solta Medical Corporation dated as of March 30, 2022 (Filed With SEC on April 28, 2022)

Amendment to Tax Matters Agreement by and between Bausch Health Companies Inc. and Bausch + Lomb Corporation, dated as of April 28, 2022 (Filed With SEC on April 28, 2022)

Arrangement Agreement by and between Bausch Health Companies Inc. and Bausch + Lomb Corporation and the other parties thereto, dated as of April 28, 2022 (Filed With SEC on April 28, 2022)

Form of Restricted Stock Unit Award Agreement (Founders Grant) under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (Filed With SEC on March 31, 2022)

Form of Common Share Certificate (Filed With SEC on March 31, 2022)

Master Separation Agreement by and between Bausch Health Companies Inc. and Bausch + Lomb Corporation, dated as of March 30, 2022 (Filed With SEC on March 31, 2022)

Transition Services Agreement by and between Bausch Health Companies Inc. and Bausch + Lomb Corporation, dated as of March 30, 2022 (Filed With SEC on March 31, 2022)

Tax Matters Agreement by and between Bausch Health Companies Inc. and Bausch + Lomb Corporation, dated as of March 30, 2022 (Filed With SEC on March 31, 2022)

Registration Rights Agreement by and between Bausch Health Companies Inc. and Bausch + Lomb Corporation, dated as of March 30, 2022 (Filed With SEC on March 31, 2022)

Employee Matters Agreement by and between Bausch Health Companies Inc. and Bausch + Lomb Corporation, dated as of March 30, 2022 (Filed With SEC on March 31, 2022)

Intellectual Property Matters Agreement by and between Bausch Health Companies Inc. and Bausch + Lomb Corporation, dated as of March 30, 2022 (Filed With SEC on March 31, 2022)

Real Estate Matters Agreement by and between Bausch Health Companies Inc. and Bausch + Lomb Corporation, dated as of March 30, 2022 (Filed With SEC on March 31, 2022)

Form of Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (Filed With SEC on March 31, 2022)

Loan Agreement by and between Bausch Health Companies Inc. and Bausch + Lomb Corporation, dated as of January 1, 2022 (Filed With SEC on March 31, 2022)

Form of Director Restricted Share Unit Award Agreement (Annual Grant) under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (Filed With SEC on March 31, 2022)

Form of Director Restricted Share Unit Award Agreement (Elective Grant) under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (Filed With SEC on March 31, 2022)

Assignment, Assumption and Amendment Agreement between Bausch Health Companies Inc., Bausch + Lomb Corporation and Joseph Papa dated as of January 3, 2022 (Filed With SEC on March 31, 2022)

Assignment, Assumption and Amendment Agreement between Bausch Health Companies Inc., Bausch + Lomb Corporation and Sam A. Eldessouky dated as of January 3, 2022 (Filed With SEC on March 31, 2022)

Assignment, Assumption and Amendment Agreement between Bausch Health Companies Inc., Bausch + Lomb Corporation and Christina M. Ackermann dated as of January 3, 2022 (Filed With SEC on March 31, 2022)

Assignment, Assumption and Amendment Agreement between Bausch Health Companies Inc., Bausch + Lomb Corporation and Joseph F. Gordon dated as of January 3, 2022 (Filed With SEC on March 31, 2022)

Form of Stock Option Grant Agreement (Founders Grant) under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (Filed With SEC on March 31, 2022)

Form of Underwriting Agreement (Filed With SEC on January 13, 2022)

Form of Indemnification Agreement (Filed With SEC on January 13, 2022)

Bausch & Lomb Corp (41)